kezar life sciences market cap
Shares of the clinical-stage biotech Kezar Life Sciences KZR-026. Kezar Announces Inducement Grant Under.
Could The Kezar Life Sciences Inc Nasdaq Kzr Ownership Structure Tell Us Something Useful
With Kezar Life Sciences stock trading at 730 per share the total value of Kezar Life Sciences stock market capitalization is 49910M.
. Kezar Life Sciences fundamental comparison. Z Score vs Market Capitalization. Kezar Life Sciences Stock Up 48 KZR stock opened at 765 on Friday.
Market Cap is a widely used stock evaluation measure. Kezar Life Sciences market cap history and chart from 2017 to 2022. Kezar Life Sciences Inc KZR 967 000 000 USD NASDAQ.
049 Billion As of October 2022 Kezar Life Sciences has a market cap of 049 Billion. View and export this data back to 2018. Market capitalization or market value is the most commonly used method of measuring the size of a publicly traded.
Kezar Life Sciences stock was originally listed at a. Thats a big deal for a clinical-stage biotech with a 600 million market cap at the time of this writing. Kezar Life Sciences Inc a clinical-stage biotechnology company engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in.
Earnings for Kezar Life Sciences KZR Earnings in 2022 TTM. Kezar Life Sciences Inc a clinical-stage biotechnology company engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in. In depth view into Kezar Life Sciences Market Cap explanation calculation historical data and more.
Kezar Life Sciences Inc. Return On Equity vs Market Capitalization. Kezar Life Sciences Inc.
This makes Kezar Life Sciences the worlds 5334th most valuable company by market. KZR IEX Real-Time Price USD 767-010 -129 Oct 7 2022 400 PM EDT - Market closed. 16 2021 0602 AM.
Kezar Life Sciences fundamental comparison. Find the latest Market Cap for Kezar Life Sciences KZR. NASDAQKZR shares are soaring Tuesday following a positive clinical readout.
KZR Market Cap as of today August 11 2022 is 60657 Mil. Kezar Life Sciences Market Cap. Kezar Life Sciences to Present Complete Results from the Phase 2 MISSION Trial of Zetomipzomib in.
In depth view into Kezar Life Sciences Market Cap Score including historical data from 2018 charts and stats. The business has a 50 day moving average of 879 and a 200 day moving average of 876. -6089 M According to Kezar Life Sciencess latest financial reports the companys current earnings TTM are -6089 MIn.
Historical Market Cap Data. Market Cap 51756M Shares Out 6837M 10 Day Average Volume 086M Dividend - Dividend Yield - Beta 021 YTD Change -5472 RATIOSPROFITABILITY EPS TTM -105 PE.
Kezar Life Sciences Stock Quote Kzr Stock Price News Charts Message Board Trades
Kzr Stock Price And Chart Nasdaq Kzr Tradingview
Kezar Life Sciences Stock Quote Kzr Stock Price News Charts Message Board Trades
Kezar Life Sciences Inc Kzr Stock Price Quote News Stock Analysis
4 Penny Stocks On Robinhood Webull To Watch With Upcoming Events
Kzr Stock Price And Chart Nasdaq Kzr Tradingview
Kezar Life Sciences Stock Chart Kzr
Kezar Life Sciences Regulatory Tailwinds Reverse Downside Case Nasdaq Kzr Seeking Alpha
Why Is Kezar Life Sciences Surging By 78 25 Stocks Moving In Tuesday S Pre Market Session Agile Therapeutics Nasdaq Agrx Aim Immunotech Amex Aim Benzinga
Kezar Life Sciences Key Catalysts Ahead Nasdaq Kzr Seeking Alpha
Kezar Life Sciences Inc Kzr Stock Price Quote News Stock Analysis
Kezar Life Sciences Latest News Tracxn
Kzr Institutional Ownership And Shareholders Kezar Life Sciences Inc Nasdaq Stock
Deck Review With Kezar Life Sciences By Joshua Elkington
Monster Moves Among Russell 3 000 Stocks Bespoke Investment Group
Biopharma Market Cap Meet Capital Investment Site Selection Magazine
Kzr Kezar Life Sciences Stock R Stockconsultant
Kezar Life Sciences Inc Shares Near 52 Week High Market Mover Nasdaq
